26.2 C
New York
Tuesday, June 9, 2026

Tag: HEA MTC

Allergy/Immunology Leaders Unite to Strengthen the Specialty Workforce and Expand Access to High Quality Care

Allergy/Immunology organizations share their commitment to support the specialty workforce, quality care, and continued improvement in clinical outcomesWASHINGTON, June 9, 2026 /PRNewswire/ -- Leaders...

Ambrosia Biosciences Announces Preclinical Data Supporting Differentiated Profile of AMB-702, its Novel Small Molecule GLP-1 Receptor Agonist Development Candidate

AMB-702 demonstrates superior target coverage and efficacy in lean non-human primates The dataset was shared as part of a poster presentation at the American Diabetes...

Bio Preventive Medicine and Precision Diabetes Announce ADA Late-Breaking Presentation Highlighting DNlite™ in Landmark CREDENCE Trial

New analysis supports DNlite™ for earlier renal risk stratification in patients with type 2 diabetes and chronic kidney diseaseZHUBEI CITY, Taiwan and RALEIGH, N.C.,...

Dong Bang Co Ltd to Showcase Veterinary Pharmaceuticals at Indo Livestock 2026

SEOUL, South Korea, June 5, 2026 /PRNewswire/ -- Dong Bang Co Ltd, a Korean veterinary pharmaceutical manufacturer, will participate in the "Indo Livestock 2026...

Quest Diagnostics to Speak at the Baird 2025 Global Healthcare Conference

SECAUCUS, N.J., Aug. 15, 2025 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), a leader in diagnostic information services, announced that Jim Davis, Chairman, CEO...

Precigen Announces Full FDA Approval of PAPZIMEOS (zopapogene imadenovec-drba), the First and Only Approved Therapy for the Treatment of Adults with Recurrent Respiratory Papillomatosis

PAPZIMEOS approval marks a historic milestone for the RRP patient community as the first and only FDA-approved therapy for the treatment of adults with...

Solventum Announces Launch of Secondary Offering of Common Stock

ST. PAUL, Minn., Aug. 13, 2025 /PRNewswire/ -- Solventum Corporation (NYSE: SOLV, "Company" or "Solventum") today announced the launch of a secondary offering (the "Offering")...

Elevating Clinical Excellence: TLCx Appoints Dr Ries as Chief Medical Officer

CEDAR RAPIDS, Iowa, Aug. 13, 2025 /PRNewswire/ -- TLCx is taking a significant step toward its long-term vision of transforming the healthcare patient experience. This...

Evolve Orthopedic Partners Launches With OrthoNY Partnership, Appoints Veteran Healthcare Executive Jerry Tillinger as CEO

Newly formed MSO to support orthopedic practices and ASCs with strategic growth, back-end operations and clinical autonomy LATHAM, N.Y., Aug. 12, 2025 /PRNewswire/ -- Evolve Orthopedic...

Azitra, Inc. Announces Q2 2025 Results and Provides Business Updates

BRANFORD, Conn., Aug. 11, 2025 /PRNewswire/ -- Azitra, Inc. ("Azitra") (NYSE American: AZTR), a clinical stage biopharmaceutical company focused on developing innovative therapies for...

REVEALING STUDY HAS REJUVANT LEADING THE LONGEVITY PACK

Renowned Longevity Researcher Reveals Highlights of New Study to NBJ Conference Guests FERNANDINA BEACH, Fla., Aug. 11, 2025 /PRNewswire/ -- Dr. Brian Kennedy, one of...

New Data Analyses from Groundbreaking Pivotal Bridge to HOPE Clinical Trial Demonstrate Statistically Significant Clinical, Economic and Immunomodulatory Advantages in Liver Transplantation

Presentations showcased at World Transplant Congress in San Francisco demonstrate HOPE reduces the cost of liver transplantation by shortening the index hospitalization and decreasing...

Ductal Carcinoma In Situ Discovery from Gynecomastia Surgery by Dr Ivan Puah

Gynecomastia can indicate underlying health concerns, including cancer, and surgery provides an opportunity to examine tissues for abnormalities. Early detection saves lives. SINGAPORE, Aug. 6,...

MDLifespan and Dr. Jill Carnahan Launch “Next Gen Mold Detox” Using Therapeutic Plasma Exchange

Dr Jill's MDLifespan Mold Protocol is the First Clinically Proven Therapeutic Plasma Exchange Detox to Remove up to 90% of Mold Toxins DENVER, Aug. 4,...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsHEA MTC